Skip to content

Xiaojin capsule versus combined norethisterone acetate treatment for endometriosis-associated deep dyspareunia- a prospectively randomized controlled trial: Effect on pain during intercourse and sexual satisfaction

Xiaojin capsule versus combined norethisterone acetate treatment for endometriosis-associated deep dyspareunia- a prospectively randomized controlled trial: Effect on pain during intercourse and sexual satisfaction

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039197
Enrollment
Unknown
Registered
2020-10-21
Start date
2020-10-08
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis-associated deep dyspareunia

Interventions

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Subjects with persistent endometriosis-associated deep dyspareunia, with or without dysmenorrhea for more than 3 months.

Exclusion criteria

Exclusion criteria: 1.obstructive uropathy or symptomatic bowel stenosis; 2.evidence of complex adnexal cysts or an ovarian endometrioma of diameter more than 4 cm at vaginal ultrasonography; 3.therapies for endometriosis other than non-steroidal anti inflammatory drugs (NSAIDs) in the 3 months before study entry (6 months for GnRH analogues); 4.the typical contraindications to progestins; 5.the use of drugs that interfere with ovarian steroid metabolism; 6.allergy to components of the study medication; 7.abnormal findings at breast examination and mammary ultrasound scan; 8.an abnormal cervical smear; 9.a diagnosis of concomitant pelvic inflammatory disease, pelvic varices or genital malformations at previous surgery; 10.known gastrointestinal, urologic and orthopedic diseases; 11.psychiatric disturbances; 12.history of drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
pain evaluation;sexual functioning questionnaire;

Countries

China

Contacts

Public ContactWu Qing

Zhejiang Provincial People's Hospital

okwq31@163.com+86 15167170568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026